18 results on '"Sharpe, Rowena"'
Search Results
2. Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial
3. Correction to: The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care
4. The National Lung Matrix Trial of personalized therapy in lung cancer
5. Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine Programme
6. TESSA JOWELL BRAIN MATRIX PLATFORM STUDY: PRELIMINARY ANALYSIS OF THE PRIMARY FEASIBILITY & PROCESS-CENTRED OBJECTIVE
7. Challenges in molecular testing in non-small-cell lung cancer patients with advanced disease
8. Publisher Correction: The National Lung Matrix Trial of personalized therapy in lung cancer
9. The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care
10. Protocol for the Tessa Jowell BRAIN MATRIX Platform Study
11. Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial
12. CATALYST trial protocol: a multicentre, open-label, phase II, multiarm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults
13. Namilumab or infliximab compared to standard of care in hospitalised patients with COVID-19 (CATALYST): a phase 2 randomised adaptive trial
14. How Cancer Research UK is adapting to adaptive designs
15. CATALYST trial protocol: A multicentre, open-label, phase II, multi-arm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults
16. CRUK Epidemiology and molecular pathology of the first 1000 participants in the Stratified Medicine Programme
17. Emerging findings in the Cancer Research UK stratified medicine program.
18. Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.